Skip to content
10-K

Annual Report

Tango Therapeutics, Inc. TNGX

0001193125-26-092518

← back to feed
Filed
Mar 5, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 26, 2026 142.69M sh
Shares Diluted FY 2025 · Dec 31, 2025 116.17M sh
Shares Diluted FY 2025 · Dec 31, 2024 109.23M sh
Shares Diluted FY 2025 · Dec 31, 2023 94.57M sh
Capex FY 2025 · Dec 31, 2025 $1.05M
Capex FY 2025 · Dec 31, 2024 $754K
Capex FY 2025 · Dec 31, 2023 $1.53M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$138.89M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$131.5M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$117.98M
Cash And Equivalents FY 2025 · Dec 31, 2025 $112.28M
Cash And Equivalents FY 2025 · Dec 31, 2024 $69.53M
Cash And Equivalents FY 2025 · Dec 31, 2023 $66.39M
Stockholders Equity FY 2025 · Dec 31, 2025 $346.18M
Stockholders Equity FY 2025 · Dec 31, 2024 $199.52M
Stockholders Equity FY 2025 · Dec 31, 2023 $253.11M
Stockholders Equity FY 2025 · Dec 31, 2022 $249.48M
Current Liabilities FY 2025 · Dec 31, 2025 $21.68M
Current Liabilities FY 2025 · Dec 31, 2024 $38.17M
Total Liabilities FY 2025 · Dec 31, 2025 $52.51M
Total Liabilities FY 2025 · Dec 31, 2024 $116.98M
Current Assets FY 2025 · Dec 31, 2025 $353.76M
Current Assets FY 2025 · Dec 31, 2024 $266.34M
Total Assets FY 2025 · Dec 31, 2025 $398.69M
Total Assets FY 2025 · Dec 31, 2024 $316.49M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.87
Eps Diluted FY 2025 · Dec 31, 2024 −$1.19
Eps Diluted FY 2025 · Dec 31, 2023 −$1.08
Eps Basic FY 2025 · Dec 31, 2025 −$0.87
Eps Basic FY 2025 · Dec 31, 2024 −$1.19
Eps Basic FY 2025 · Dec 31, 2023 −$1.08
Sga Expense FY 2025 · Dec 31, 2025 $41.51M
Sga Expense FY 2025 · Dec 31, 2024 $43.75M
Sga Expense FY 2025 · Dec 31, 2023 $35.5M
Rd Expense FY 2025 · Dec 31, 2025 $132.17M
Rd Expense FY 2025 · Dec 31, 2024 $143.92M
Rd Expense FY 2025 · Dec 31, 2023 $115.2M
Net Income FY 2025 · Dec 31, 2025 −$101.59M
Net Income FY 2025 · Dec 31, 2024 −$130.3M
Net Income FY 2025 · Dec 31, 2023 −$101.74M
Operating Income FY 2025 · Dec 31, 2025 −$111.29M
Operating Income FY 2025 · Dec 31, 2024 −$145.6M
Operating Income FY 2025 · Dec 31, 2023 −$114.17M
Revenue FY 2025 · Dec 31, 2025 $62.38M
Revenue FY 2025 · Dec 31, 2024 $42.07M
Revenue FY 2025 · Dec 31, 2023 $36.53M